Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 30;13(4):653-656.
doi: 10.21037/tau-23-578. Epub 2024 Apr 11.

A critical evaluation of Optilume® BPH as a novel minimally invasive surgical treatment for the management of lower urinary tract symptoms in men

David C Chen  1   2   3   4 , Alice Thomson  1   4 , Siyu Huang  1   4 , Declan G Murphy  1   4 , Damien Bolton  2   4 , Nathan Lawrentschuk  1   4   5 , Marlon L Perera  1   2   4   5
Affiliations
Editorial

A critical evaluation of Optilume® BPH as a novel minimally invasive surgical treatment for the management of lower urinary tract symptoms in men

David C Chen et al. Transl Androl Urol. .
No abstract available

Keywords: Optilume® BPH; Prostate; benign prostate hyperplasia (BPH); minimally invasive surgical therapies (MIST).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-578/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Kaplan SA, Moss J, Freedman S, et al. The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol 2023;210:500-9. 10.1097/JU.0000000000003568 - DOI - PubMed
    1. Lee YJ, Lee JW, Park J, et al. Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea. Investig Clin Urol 2016;57:424-30. 10.4111/icu.2016.57.6.424 - DOI - PMC - PubMed
    1. İbis MA, Cayan S, Tokatli Z, et al. Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study. Turk J Urol 2021;47:501-8. 10.5152/tud.2021.21262 - DOI - PMC - PubMed
    1. Elliott SP, Coutinho K, Robertson KJ, et al. One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume(®) Drug-Coated Balloon for Anterior Urethral Strictures. J Urol 2022;207:866-75. 10.1097/JU.0000000000002346 - DOI - PubMed
    1. Pichardo M, Rijo E, Espino G, et al. Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study. World J Urol 2023;41:2209-15. 10.1007/s00345-023-04473-1 - DOI - PubMed